Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
Is a |
Product manufactured as otic dose form (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
Is a |
Product containing benzocaine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Benzocaine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenazone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
Is a |
Product containing benzocaine and phenazone (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Non-opioid analgesics |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
Is a |
Product containing glycerol (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Glycerol |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
Is a |
Glycerol-containing product in otic dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
Has manufactured dose form |
Otic dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
Is a |
Product containing benzocaine in otic dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
Has manufactured dose form |
Ear solution |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
Is a |
Product containing amino acid and glycerol |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Antipyrine + benzocaine 5.4%wv/1.442%wv solution |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|